Former Air Force Surgeon General Joins Integrated Medical Systems’ Advisory Board
SIGNAL HILL, Calif., Feb. 11 /PRNewswire/ — Integrated Medical Systems, Inc., a medical technology systems integrator transforming critical care, announced that former United States Air Force Surgeon General James Roudebush, M.D., has joined the Company’s external Board of Advisors.
As U.S. Air Force Surgeon General, Dr. Roudebush served as the senior medical advisor to the Secretary of the Air Force, and provided direction to over 40,000 military medical personnel assigned to 75 hospitals and clinics worldwide. Dr. Roudebush has long experience in joint operations, having served as the Command Surgeon for U.S. Transportation Command, and Command Surgeon for U.S. Central Command, responsible for all US military medical support operations in the Horn of Africa, the Middle East and southwest Asia. Dr. Roudebush received his bachelor’s degree from the University of Nebraska, and his Doctor of Medicine degree from the University of Nebraska, College of Medicine.
“Dr. Roudebush brings an unmatched combination of accomplishment, insight and leadership propelling a shared goal to transform critical care,” noted Todd Kneale, president and chief operating officer of Integrated Medical Systems, Inc. “We welcome Dr. Roudebush contributing his talent to our august Board of Advisors as we accelerate into new market segments.”
Dr. Roudebush notes, “There’s nothing more important to me than ensuring the absolute best medical care for our sons and daughters in harm’s way, whether on the battlefield or on our city streets. Since we already have the best caregivers in the world, it’s critically important we equip them with the best care technologies in the world. IMS has proven its ability to design, manufacture and field such breakthrough solutions, and I’m proud to be associated with this world-renowned team.”
About the LS-1(TM) “Suitcase Intensive Care Unit”(TM)
The LS-1 is a portable unit intended to supply ICU functionality for adult and pediatric patients. The LS-1 combines the following medical device capabilities into a single platform: physiological monitoring (electrocardiogram, invasive pressure monitoring, non-invasive blood pressure monitoring, temperature, blood oxygen saturation, and heart rate), low rate and high rate infusion pumps, a fluid warmer, a ventilator with carbon dioxide monitoring capabilities and the ability to deliver oxygen to a patient. The functions of the LS-1 are controlled from a central user interface. The LS-1 may be operated using either hot-swappable battery power or an external source. The unit can accept external high pressure or low pressure sources of oxygen. A USB Port provides connectivity to an external printer, and allows for a connection of a USB flash drive to off-load (download) logged data. An Ethernet Port allows for Local Area Network (LAN) connectivity. The LS-1 is intended to be used in hospitals, aircraft, ambulances, field hospitals, and extended care facilities. A future upgrade will allow additional medical devices to be added using the Auxiliary Device Port and be controlled and displayed through the LS-1.
The purpose of the LS-1 is to help support continuous patient care during transport from outside of the hospital or within the hospital environment. Current practice includes frequently disconnecting and reconnecting a patient from therapy and monitoring when a patient is transported. During transport, caregivers have to juggle multiple medical devices and when they arrive at a destination, connect the devices to a central computer. Use of the LS-1 not only increases patient safety, but caregiver efficiency, as well. Clinical studies with the predicate device, the LSTAT(TM) stretcher-based integrated patient care platform, demonstrated the need for fewer caregivers during transport, faster response time to adverse events, faster ‘time to go’ between wards, and potential reduction in the hospital length-of-stay (“Life Support for Trauma and Transport: a mobile ICU for safe in-hospital transport of critically injured patients”, Velmahos et al, Journal of the American College of Surgeons, 2004 July;199 (1):62-8).
About Integrated Medical Systems, Inc.
Integrated Medical Systems, Inc. (IMS) is the leading innovator in the development of fully integrated products for critical care. Our firm, whose principal shareholders include Northrop Grumman Corporation (NGC), is committed to the rapid deployment of products that include portable intensive care systems, advanced diagnostic and therapeutic devices, telemedicine networks, and related information systems. IMS has been recognized by the Governor of California as among the Top 100 Tech firms in California; by Los Angeles Business Journal as among the Top 25 Biomed/Biotech firms in the greater Los Angeles region; and by Fast Company magazine as among the 50 Most Influential Companies. For more information on IMS and the LS-1 “suitcase ICU”, please visit www.LSTAT.com
SOURCE Integrated Medical Systems, Inc.